Skip to main content

Table 5 Cancer yield, FPR and FPB results for mammography (A), MRI (B), and the combination (C)

From: The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI

Age category

Risk category

Cancer yielda (95% CI)

FPRa (95% CI)

FPBa (95% CI)

A. Mammography

 <  40 years

Overall

6.54 (3.73–11.46)

36.06 (27.57–47.03)

19.48 (13.73–27.58)

BRCA

7.17 (3.61–14.18)

26.96 (18.07–40.03)

15.52 (9.03–26.57)

No BRCA

5.61 (2.10–14.89)

49.62 (34.62–70.64)

24.94 (15.94–38.83)

 40–50 years

Overall

6.35 (3.71–10.83)

40.44 (31.53–51.72)

24.23 (17.66–33.16)

BRCA

6.78 (2.85–16.02)

18.90 (11.26–31.56)

12.21 (6.37–23.30)

No BRCA

6.11 (3.08–12.06)

52.66 (39.80–69.38)

30.56 (21.36–43.55)

 50–60 years

Overall

13.57 (9.21–19.94)

33.28 (24.94–44.29)

18.38 (12.60–26.75)

BRCA

26.10 (15.93–42.47)

10.56 (4.75–23.31)

8.85 (3.67–21.15)

No BRCA

7.89 (4.26–14.58)

43.06 (31.68–58.27)

22.16 (14.61–33.47)

 ≥ 60 years

Overall

17.72 (10.81–28.93)

25.82 (16.76–39.58)

10.88 (5.64–20.90)

BRCA

21.48 (7.99–56.49)

10.69 (2.64–42.22)

0.00 (N/A)

No BRCA

16.90 (9.54–29.77)

30.38 (19.27–47.57)

14.14 (7.31–27.15)

 Overall

Overall

9.95 (7.80–12.69)

36.42 (31.42–42.19)

20.05 (16.49–24.37)

BRCA

12.44 (8.75–17.65)

20.65 (15.32–27.77)

12.56 (8.50–18.51)

No BRCA

8.33 (5.95–11.65)

47.08 (39.74–55.71)

24.95 (19.91–31.24)

B. MRI

 <  40 years

Overall

13.09 (8.80–19.44)

87.25 (74.68–101.71)

62.30 (51.89–74.63)

BRCA

14.31 (8.81–23.16)

75.49 (60.59–93.70)

56.72 (44.03–72.79)

No BRCA

11.22 (5.61–22.31)

104.96 (84.38–129.84)

70.70 (54.44–91.35)

 40–50 years

Overall

14.06 (9.83–20.07)

70.45 (59.44–83.31)

55.95 (46.39–67.33)

BRCA

18.86 (11.26–31.42)

47.03 (34.06–64.61)

34.73 (23.93–50.15)

No BRCA

11.37 (6.91–18.66)

82.49 (67.63–100.27)

67.55 (54.44–83.53)

 50–60 years

Overall

19.56 (14.16–26.96)

41.64 (32.53–53.16)

29.88 (22.29–39.94)

BRCA

40.37 (27.00–59.96)

44.36 (29.42–66.36)

30.66 (18.27–51.02)

No BRCA

10.25 (5.97–17.55)

40.08 (29.42–54.38)

29.41 (20.59–41.84)

 ≥ 60 years

Overall

23.56 (15.39–35.93)

29.04 (19.45–43.15)

20.49 (12.72–32.85)

BRCA

21.48 (7.99–56.49)

10.85 (2.66–43.12)

10.85 (2.66–43.12)

No BRCA

24.40 (15.23–38.87)

34.37 (22.63–51.89)

23.31 (14.04–38.45)

 Overall

Overall

16.64 (13.81–20.04)

62.52 (56.37–69.29)

46.27 (41.11–52.06)

BRCA

22.08 (17.03–28.60)

56.98 (48.07–67.42)

41.81 (34.35–50.80)

No BRCA

13.10 (10.02–17.10)

66.13 (58.03–75.27)

49.21 (42.42–57.03)

C. Combination

 <  40 years

Overall

13.56 (9.24–20.10)

99.78 (86.35–115.04)

65.68 (54.96–78.31)

BRCA

14.31 (8.81–23.16)

85.01 (69.45–103.66)

60.34 (47.29–76.70)

No BRCA

12.65 (6.58–24.21)

121.64 (99.00–148.59)

73.85 (56.96–95.26)

 40–50 years

Overall

15.02 (10.64–21.17)

89.74 (77.29–103.98)

63.26 (53.13–75.18)

BRCA

18.86 (11.26–31.42)

57.42 (42.61–76.97)

42.39 (29.86–59.85)

No BRCA

12.89 (8.10–20.48)

107.19 (90.27–126.84)

74.68 (61.11–90.97)

 50–60 years

Overall

23.82 (17.82–31.76)

60.11 (48.79–73.85)

36.58 (28.05–47.59)

BRCA

45.29 (31.14–65.43)

47.62 (32.20–69.90)

33.91 (20.91–54.54)

No BRCA

14.16 (8.97–22.29)

65.53 (51.26–83.42)

37.51 (27.28–51.37)

 ≥ 60 years

Overall

26.49 (17.31–40.36)

46.86 (34.05–64.17)

24.16 (15.57–37.33)

BRCA

21.48 (7.99–56.49)

22.05 (8.12–58.46)

10.85 (2.66–43.12)

No BRCA

27.87 (17.39–44.38)

54.21 (38.71–75.43)

28.06 (17.67–44.30)

 Overall

Overall

18.68 (15.65–22.27)

79.65 (72.70–87.21)

51.73 (46.28–57.78)

BRCA

23.17 (18.00–29.79)

65.59 (56.09–76.55)

46.14 (38.31–55.47)

No BRCA

15.74 (12.28–20.15)

89.14 (79.65–99.64)

55.39 (48.20–63.57)

  1. aGeneral estimating equations were used to calculate performance measures, correcting for multiple screening rounds within the same patient. All measurements are per 1000 examinations
  2. MRI magnetic resonance imaging, N/A no cancers, recalls, or biopsies were found in this category and no 95% CI of this measure could be calculated, 95% CI Wald 95% confidence intervals